- News Home
12 December 2013 1:00 pm ,
Vol. 342 ,
The iconic 125-year-old Lick Observatory on Mount Hamilton near San Jose, California, is facing the threat of closure...
Recent results from the Curiosity Mars rover have helped scientists formulate a plan for the next phase of its mission...
A new, remarkably powerful drug that cripples the hepatitis C virus (HCV) came to market last week, but it sells for $...
In pretoothbrush populations, gumlines would often be marred by a thick, visible crust of calcium phosphate, food...
Evolutionary biologists have long studied how the Mexican tetra, a drab fish that lives in rivers and creeks but has...
Victorian astronomers spent countless hours laboriously charting the positions of stars in the sky. Such sky mapping,...
In an ambitious project to study 1000 years of sickness and health, researchers are excavating the graveyard of the now...
Stefan Behnisch has won awards for designing science labs and other buildings that are smart, sustainable, and...
- 12 December 2013 1:00 pm , Vol. 342 , #6164
- About Us
So Long Aspirin, Hello Silver
28 May 2009 (All day)
Millions of people around the world are prone to dangerous blood clots. Now researchers have had early success with a new way to prevent them--and the strokes, heart attacks, and pulmonary embolisms they cause. Nano-sized particles of silver can stop sticky blood cells called platelets from clinging together in laboratory strains of mice, the team reports.
Platelets help the body stop bleeding. But if they clump together too much, they can also form clots within the bloodstream. A deep-vein thrombosis, for example, can form in the lower leg and block blood flow. If the clot is not broken up quickly using injections of powerful anticoagulants, it can break loose and cut blood supply to the heart or brain, with fatal consequences. As a result, the nearly 500 million sufferers worldwide of clotting-related disorders--including this reporter--must take daily doses of anticoagulants, which carry dangers of their own, such as spontaneous and uncontrollable internal bleeding.
The key, then, is to find an agent that prevents platelets from sticking together too much without impeding their ability to shunt a bleed. Recent research on silver nanoparticles--tiny grains of the metal less than 1/50,000th the width of a human hair--indicated that they might do the trick. So a biomedical team from Banaras Hindu University in Varanasi, India, began exploring their potential, in cooperation with materials science colleagues at the university and at the International Advanced Research Centre for Powder Metallurgy and New Materials in Balapur, India.
The researchers injected mice with blood genetically engineered to be prone to clotting and then administered the nano-silver. As the team reports online in ACS Nano, the nano-silver particles inhibit the ability of the sticky platelet surface proteins to bind these cells together into aggregates, much like adding sand to adhesive tape reduces its ability to stick. "This helps the nano-silver to keep platelets in an inactive state," says biochemist and co-author Debabrata Dash of Banaras. The nanoparticles were "far more effective" than current therapies, he adds. At the same time, the nanoparticles don't interfere with the other proteins in the blood that help form clots, as do conventional anticoagulants, so the danger of uncontrolled bleeding is reduced.
Dash notes that the nanoparticles appear "to be fairly safe to human beings," but like any other new medical technique, they will have to be studied for potential toxic effects.
Cellular biologist Jonathan Gibbins of the University of Reading in the United Kingdom agrees that caution is warranted. "The work is at a relatively early stage, with key questions such as potential toxicity and mechanisms of action remaining to be addressed," he says. "But this certainly is a new and unexpected dimension to platelet research." Likewise, biochemist Stan Heptinstall of the University of Nottingham in the United Kingdom cautions that the research is "at the very beginning." The key issue, he says, is whether the nano-silver will compromise the body's important blood-clotting functions in humans.